

Profectus Biosciences is a R&D company developing vaccine and small molecules to treat and prevent viral diseases and cancers. Among its major competitors, Profectus Biosciences is ranked in 7th place for NPS while Sanofi is 1st, and Pfizer is 2nd.Their current valuation is $89.50M